Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
- PMID: 21309058
- DOI: 10.1002/dmrr.1177
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
Abstract
Background: Fibroblast growth factor (FGF) 21, a novel member of the FGF family, plays a role in a variety of endocrine functions, including regulation of glucose and lipid metabolism. The role of FGF21 in skeletal muscle is currently not known.
Methods: Serum levels and skeletal muscle mRNA of FGF21 were determined in normal glucose tolerant (n = 40) and type 2 diabetic (T2D; n = 40) subjects. We determined whether FGF21 has direct effects on glucose metabolism in cultured myotubes (n = 8) and extensor digitorum longus skeletal muscle.
Results: Serum FGF21 levels increased 20% in T2D versus normal glucose tolerant subjects (p < 0.05), whereas skeletal muscle mRNA expression was unaltered. Fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), waist circumference, and body mass index (BMI) significantly correlated with serum FGF21 levels in T2D (p < 0.01), but not in normal glucose tolerant subjects. Serum FGF21 concentrations were greater in T2D patients in the highest tertile of fasting insulin (p < 0.05) and BMI (p < 0.05). Stepwise regression analysis identified BMI as the strongest independent variable correlating with FGF21. FGF21 exposure increased basal and insulin-stimulated glucose uptake in human myotubes, coincident with increased glucose transporter 1 mRNA, and enhanced glucose transporter 1 abundance at the plasma membrane. In isolated extensor digitorum longus muscle, FGF21 potentiated insulin-stimulated glucose transport, without altering phosphorylation of Akt or AMP-activated protein kinase.
Conclusions: Plasma FGF21 is increased in T2D patients, and positively correlated with fasting insulin and BMI. However, FGF21 has direct effects in enhancing skeletal muscle glucose uptake, providing additional points of regulation that may contribute to the beneficial effects of FGF21 on glucose homeostasis. Whether increased plasma FGF21 in T2D is a compensatory mechanism to increase glucose metabolism remains to be determined.
Copyright © 2011 John Wiley & Sons, Ltd.
Similar articles
-
Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.Endocrine. 2016 Jul;53(1):97-106. doi: 10.1007/s12020-015-0845-x. Epub 2016 Jan 12. Endocrine. 2016. PMID: 26758997
-
Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.Eur J Endocrinol. 2012 Sep;167(3):301-9. doi: 10.1530/EJE-12-0357. Epub 2012 Jun 27. Eur J Endocrinol. 2012. PMID: 22740503 Review.
-
Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation.Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E106-15. doi: 10.1152/ajpendo.00457.2002. Epub 2003 Mar 4. Am J Physiol Endocrinol Metab. 2003. PMID: 12618360
-
Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.Clin Endocrinol (Oxf). 2009 Sep;71(3):369-75. doi: 10.1111/j.1365-2265.2008.03502.x. Epub 2008 Dec 11. Clin Endocrinol (Oxf). 2009. PMID: 19702724
-
Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease.Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):354-9. doi: 10.1097/MCO.0b013e328346a326. Curr Opin Clin Nutr Metab Care. 2011. PMID: 21505329 Review.
Cited by
-
High-Protein Intake during Weight Loss Therapy Eliminates the Weight-Loss-Induced Improvement in Insulin Action in Obese Postmenopausal Women.Cell Rep. 2016 Oct 11;17(3):849-861. doi: 10.1016/j.celrep.2016.09.047. Cell Rep. 2016. PMID: 27732859 Free PMC article. Clinical Trial.
-
Do Sugar-Sweetened Beverages Increase Fasting FGF21 Irrespective of the Type of Added Sugar? A Secondary Exploratory Analysis of a Randomized Controlled Trial.Nutrients. 2022 Oct 7;14(19):4169. doi: 10.3390/nu14194169. Nutrients. 2022. PMID: 36235821 Free PMC article. Clinical Trial.
-
FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance.Cell Rep. 2021 Mar 23;34(12):108893. doi: 10.1016/j.celrep.2021.108893. Cell Rep. 2021. PMID: 33761350 Free PMC article.
-
Expression and secretion of SPARC, FGF-21 and DCN in bovine muscle cells: Effects of age and differentiation.PLoS One. 2024 Jul 3;19(7):e0299975. doi: 10.1371/journal.pone.0299975. eCollection 2024. PLoS One. 2024. PMID: 38959242 Free PMC article.
-
Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans.Mol Metab. 2015 Jun 12;4(8):551-60. doi: 10.1016/j.molmet.2015.06.001. eCollection 2015 Aug. Mol Metab. 2015. PMID: 26266087 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical